Literature DB >> 12619862

The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart.

James N Tsoporis1, Alexander Marks, Danna B Zimmer, Chris McMahon, Thomas G Parker.   

Abstract

S100A1 and S100B are members of a family of 20 kDa Ca2+-binding homodimers that play a role in signal transduction in mammalian cells. S100A1 is the major isoform in normal heart and S100B, normally a brain protein, is induced in hypertrophic myocardium and functions as an intrinsic negative modulator of the hypertrophic response. In order to examine the function of S100A1, we first showed that, in contrast to S100B, S100A1 was downregulated in rat experimental models of myocardial hypertrophy following myocardial infarction or pressure overload. Second, in co-transfection experiments in cultured neonatal rat cardiac myocytes, S100A1 inhibited the alpha1-adrenergic activation of promoters of genes induced during the hypertrophic response including the fetal genes skeletal alpha actin (skACT), and beta-myosin heavy chain (MHC) and S100B, but not the triiodothyronine (T3) activation of the promoter of the alpha-MHC gene, that is normally expressed in adult myocardium. These results suggest that S100A1 is involved in the maintenance of the genetic program that defines normal myocardial function and that its downregulation is permissive for the induction of genes that underlie myocardial hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619862

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

Review 1.  Switches in cardiac muscle gene expression as a result of pressure and volume overload.

Authors:  K Schwartz; K R Boheler; D de la Bastie; A M Lompre; J J Mercadier
Journal:  Am J Physiol       Date:  1992-03

2.  Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes.

Authors:  N H Bishopric; P C Simpson; C P Ordahl
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  S100A1 utilizes different mechanisms for interacting with calcium-dependent and calcium-independent target proteins.

Authors:  A Landar; R R Rustandi; D J Weber; D B Zimmer
Journal:  Biochemistry       Date:  1998-12-15       Impact factor: 3.162

4.  Cloning and expression of the human S100 beta gene.

Authors:  R J Allore; W C Friend; D O'Hanlon; K M Neilson; R Baumal; R J Dunn; A Marks
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

5.  Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy.

Authors:  A Remppis; T Greten; B W Schäfer; P Hunziker; P Erne; H A Katus; C W Heizmann
Journal:  Biochim Biophys Acta       Date:  1996-10-11

6.  Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.

Authors:  P Simpson
Journal:  Circ Res       Date:  1985-06       Impact factor: 17.367

7.  Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter.

Authors:  K Kariya; I K Farrance; P C Simpson
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth.

Authors:  L R Karns; K Kariya; P C Simpson
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

9.  Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma.

Authors:  Q Yang; D O'Hanlon; C W Heizmann; A Marks
Journal:  Exp Cell Res       Date:  1999-02-01       Impact factor: 3.905

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  8 in total

1.  Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.

Authors:  Patrick Most; Sven T Pleger; Mirko Völkers; Beatrix Heidt; Melanie Boerries; Dieter Weichenhan; Eva Löffler; Paul M L Janssen; Andrea D Eckhart; Jeffrey Martini; Matthew L Williams; Hugo A Katus; Andrew Remppis; Walter J Koch
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1.

Authors:  Naohiro Yamaguchi; Benjamin L Prosser; Farshid Ghassemi; Le Xu; Daniel A Pasek; Jerry P Eu; Erick O Hernández-Ochoa; Brian R Cannon; Paul T Wilder; Richard M Lovering; David Weber; Werner Melzer; Martin F Schneider; Gerhard Meissner
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

3.  S100A1 in human heart failure: lack of recovery following left ventricular assist device support.

Authors:  Mosi K Bennett; Wendy E Sweet; Sara Baicker-McKee; Elizabeth Looney; Kristen Karohl; Maria Mountis; W H Wilson Tang; Randall C Starling; Christine S Moravec
Journal:  Circ Heart Fail       Date:  2014-05-19       Impact factor: 8.790

4.  Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.

Authors:  Sven T Pleger; Changguang Shan; Jan Ksienzyk; Raffi Bekeredjian; Peter Boekstegers; Rabea Hinkel; Stefanie Schinkel; Barbara Leuchs; Jochen Ludwig; Gang Qiu; Christophe Weber; Philip Raake; Walter J Koch; Hugo A Katus; Oliver J Müller; Patrick Most
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

5.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07

6.  Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.

Authors:  C Weber; I Neacsu; B Krautz; P Schlegel; S Sauer; P Raake; J Ritterhoff; A Jungmann; A B Remppis; M Stangassinger; W J Koch; H A Katus; O J Müller; P Most; S T Pleger
Journal:  Gene Ther       Date:  2013-12-05       Impact factor: 5.250

Review 7.  Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review.

Authors:  Egidio Imbalzano; Giuseppe Mandraffino; Marco Casciaro; Sebastiano Quartuccio; Antonino Saitta; Sebastiano Gangemi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

8.  Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion.

Authors:  Azadeh Mofid; Nadav S Newman; Paul J H Lee; Cynthia Abbasi; Pratiek N Matkar; Dmitriy Rudenko; Michael A Kuliszewski; Hao H Chen; Kolsoom Afrasiabi; James N Tsoporis; Anthony O Gramolini; Kim A Connelly; Thomas G Parker; Howard Leong-Poi
Journal:  J Am Heart Assoc       Date:  2017-02-07       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.